Betydningen af nedsat leverfunktion for farmakokinetik for atazanavir 300 mg med ritonavir er ikke undersøgt.
The effects of hepatic impairment on the pharmacokinetics of atazanavir after a 300 mg dose with ritonavir have not been studied.